{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:45:20Z","timestamp":1781887520104,"version":"3.54.5"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038390","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T21:01:37Z","timestamp":1339534897000},"page":"e38390","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response"],"prefix":"10.1371","volume":"7","author":[{"given":"Zhongsheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"ref1","year":"2011"},{"key":"ref2","first-page":"41","article-title":"Hepatitis C virus infection, N Engl J Med","volume":"345","author":"GM Lauer","year":"2001"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection.","volume":"5","author":"CW Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref5","first-page":"1350","article-title":"Treating viral hepatitis C: efficacy, side effects and complications, Gut","volume":"55","author":"MP Manns","year":"2006"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.22242","article-title":"Virological and immunological determinants of intrahepatic virus-specific CD8<sup>+<\/sup> T-cell failure in chronic hepatitis C virus infection.","volume":"47","author":"C Neumann-Haefelin","year":"2008","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2249.2004.02544.x","article-title":"Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy.","volume":"137","author":"E Tsubouchi","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.20592","article-title":"Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection.","volume":"41","author":"A Ulsenheimer","year":"2005","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clim.2006.12.001","article-title":"Differential dysfunction in dendritic cell subsets during chronic HCV infection.","volume":"123","author":"L Averill","year":"2007","journal-title":"Clin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2893.2009.01231.x","article-title":"Hepatitis C virus modulates human monocyte-derived dendritic cells.","volume":"17","author":"EA Eksioglu","year":"2010","journal-title":"J Viral Hepat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04079","article-title":"Adaptive immune responses in acute and chronic hepatitis C virus infection.","volume":"436","author":"DG Bowen","year":"2005","journal-title":"Nature"},{"key":"ref12","first-page":"104","article-title":"Comprehensive analyses of CD8<sup>+<\/sup> T cell responses during longitudinal study of acute human hepatitis C. Hepatology","volume":"42","author":"AL Cox","year":"2005"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.","volume":"45","author":"A Penna","year":"2007","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","article-title":"Tim-3 expression on PD-1<sup>+<\/sup> HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte directed in vitro cytotoxicity.","volume":"120","author":"RH McMahan","year":"2010","journal-title":"J Clin Invest 2010"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2893.2008.01058.x","article-title":"Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.","volume":"16","author":"L Alvarez-Lajonchere","year":"2009","journal-title":"J Viral Hepat"},{"key":"ref16","first-page":"1289","article-title":"A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology","volume":"38","author":"F Nevens","year":"2003"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1053\/j.gastro.2008.02.058","article-title":"Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.","volume":"134","author":"CS Klade","year":"2008","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2249.2006.03281.x","article-title":"Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.","volume":"147","author":"M Shi","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.cji.0000171291.72039.e2","article-title":"Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cell a clinical trial.","volume":"28","author":"WC Lee","year":"2005","journal-title":"J Immunother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic cell vaccine for chronic HIV-1 infection.","volume":"10","author":"W Lu","year":"2004","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","article-title":"PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.","volume":"17","author":"MA Cheever","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2010.05.007","article-title":"A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.","volume":"53","author":"EJ Gowans","year":"2010","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00535-011-0377-y","article-title":"Dendritic cells in hepatitis C infection: can they (help) win the battle?","volume":"46","author":"A Dolganiuc","year":"2011","journal-title":"J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jhep.2010.09.040","article-title":"Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.","volume":"54","author":"J Torresi","year":"2011","journal-title":"J Hepatol"},{"key":"ref25","article-title":"Complete hepatitis C virus genome cDNA isolated from mainland of China.","author":"SL Bi","year":"1993"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.vaccine.2004.02.005","article-title":"Prediction of CTL epitopes using QM, SVM and ANN techniques.","volume":"22","author":"M Bhasin","year":"2004","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1128\/JVI.76.12.6104-6113.2002","article-title":"Comprehensive anysis of CD8<sup>+<\/sup> T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.","volume":"76","author":"GM Lauer","year":"2002","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/vim.2007.0064","article-title":"The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.","volume":"20","author":"Y Tian","year":"2007","journal-title":"Viral Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.4049\/jimmunol.176.10.6065","article-title":"Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.","volume":"176","author":"W Li","year":"2006","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","article-title":"Generation of mature dendritic cells from human blood an improved method with special regard to clinical applicability.","volume":"196","author":"N Romani","year":"1996","journal-title":"J Immunol Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.vaccine.2010.01.061","article-title":"Two-step maturation of immature DCs with proinflammatory cytokine cocktail and poly(I:C) enhances migratory and T cell stimulatory capacity.","volume":"28","author":"HJ Kim","year":"2010","journal-title":"Vaccine"},{"key":"ref32","first-page":"1","article-title":"The Granzyme B ELISPOT assay: an alternative to the <sup>51<\/sup>Cr-release assay for monitoring cell-mediated cytotoxicity.","volume":"1","author":"K Shafer-Weaver","year":"2004","journal-title":"J Transl Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jim.2005.10.009","article-title":"Evaluating antigen- specific cytotoxic T lymphocyte responses by a novel mouse granzyme B ELISPOT assay.","volume":"308","author":"CL Ewen","year":"2006","journal-title":"J Immunol Methods"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection.","volume":"5","author":"B Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2004.06.015","article-title":"High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.","volume":"127","author":"GM Lauer","year":"2004","journal-title":"Gastroenterology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/jhep.2003.50115","article-title":"Novel CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.","volume":"37","author":"AM Wertheimer","year":"2003","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","article-title":"Broad repertoire of the CD4<sup>+<\/sup> Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes.","volume":"175","author":"J Schulze zur Wiesch","year":"2005","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2007.08.004","article-title":"Therapeutic potential of dendritic cell-based immunization against HBV in transgenic mice.","volume":"77","author":"WZ Jiang","year":"2008","journal-title":"Antivir Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.vaccine.2009.02.088","article-title":"Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.","volume":"27","author":"CS Klade","year":"2009","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2010.09.042","article-title":"Spontaneous control of HCV is associated with expression of HLA-B57 and preservation of targeted epitopes.","volume":"140","author":"AY Kim","year":"2011","journal-title":"Gastroenterology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.vaccine.2008.10.024","article-title":"A clinical grade poly I:C-analogue (Ampligen<sup>R<\/sup>) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro.","volume":"27","author":"H Navabia","year":"2009","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.4049\/jimmunol.0902522","article-title":"Dendritic cell inhibition is connected to during chronic hepatitis C virus infection exhaustion of CD8<sup>+<\/sup> T cell polyfunctionality during chronic hepatitis C virus infection.","volume":"184","author":"IG Rodrigue-Gervais","year":"2010","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-006-0185-3","article-title":"Identification of CTL epitopes in hepatitis C virus by a genome-wide computational scanning and a rational design of peptide vaccine.","volume":"59","author":"T Mashiba","year":"2007","journal-title":"Immunogenetics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0167-7799(96)10050-0","article-title":"Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design.","volume":"14","author":"IM Chaiken","year":"1996","journal-title":"Trends Biotechnol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1053\/jhep.2001.25091","article-title":"Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.","volume":"33","author":"S Urbani","year":"2001","journal-title":"Hepatology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","article-title":"Cell-mediated immunity and the outcome of hepatitis C virus infection.","volume":"58","author":"NH Shoukry","year":"2004","journal-title":"Annu Rev Microbiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510240102","article-title":"Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.","volume":"24","author":"TV Cacciarelli","year":"1996","journal-title":"Hepatology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/09629359890992","article-title":"Circulating Th1 and Th2 cytokines in patients with hepatitis Cvirus infection.","volume":"7","author":"XG Fan","year":"1998","journal-title":"Mediat Inflamm"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.510250233","article-title":"Detection of type 2-like T helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity.","volume":"25","author":"SL Tsai","year":"1997","journal-title":"Hepatology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.23275","article-title":"Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8<sup>+<\/sup> T-cell epitope.","volume":"51","author":"C Neumann-Haefelin","year":"2010","journal-title":"Hepatology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.3748\/wjg.v11.i46.7302","article-title":"Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta analysis.","volume":"11","author":"X Hong","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcv.2004.03.006","article-title":"Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus.","volume":"30","author":"EJ Gowans","year":"2004","journal-title":"J Clin Virol"}],"updated-by":[{"DOI":"10.1371\/annotation\/2ea71143-c033-43ff-8282-781b76c0a054","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T00:00:00Z","timestamp":1347840000000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:30:58Z","timestamp":1589041858000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038390"}},"subtitle":[],"editor":[{"given":"Jianqing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038390","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/2ea71143-c033-43ff-8282-781b76c0a054","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,12]]}}}